Seattle Genetics reported earnings on Tuesday. Despite the solid growth in sales, shares opened down today, possibly due to conservative guidance for the year ahead. Adcetris sales in the U.S. and ...
Seattle Genetics and Bayer HealthCare will collaborate on developing new antibody-drug conjugates (ADCs). Bayer is paying up-front and option exercise fees of up to $20 million for rights to use ...
Clay Siegall is the founder and CEO of Seattle Genetics. Anthony Bolante | PSBJ To continue reading this content, please enable JavaScript in your browser settings ...
99.2 Proceeds Agreement, dated May 15, 2017, by and between the Adviser and Felix J. Baker.
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Drug development partner Takeda is paying Seattle Genetics ...
Seattle Genetics releases earnings on Thursday after the bell. Here are three things you should pay attention to as the company reports its first-quarter earnings. Beat and raise?As part of its fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results